Claritev CorporationCTEV

$29.42-0.33 (-1.11%)
NYSEHealthcare24:00 UTC

Company snapshot

Market Cap
$491M
Small-cap
-4%
2025 — today
10-Year Price
-8%
2025 — today
52-Week Range
$13.47$72.58
Current $29.42· 27%

Claritev Corporation, together with its affiliated companies, provides advanced data analytics and technology-enabled services focused on cost management, payment optimization, and revenue assurance for the healthcare sector across the United States. The company offers a suite of services designed to reduce medical expenses. This includes analytics-driven solutions that utilize sophisticated algorithms and data insights to pinpoint billing overcharges, subsequently assisting with or recommending appropriate reimbursement negotiations. Additionally, their network-focused services secure discounted rates through contracts with healthcare providers and provide outsourced administration for these provider networks. Claritev also specializes in payment and revenue integrity, identifying and removing erroneous or unwarranted charges processed during claims, while simultaneously working to identify, recover, and safeguard underpaid premium amounts. Furthermore, their data and decision science offerings encompass a range of solutions that apply modern data science methodologies—including descriptive, predictive, and prescriptive analytics—to refine benefit plan structures, aid strategic decision-making, enhance patient clinical results, and ultimately lower overall healthcare costs. The company also handles business-to-business healthcare payment processing and other related services. Their diverse clientele includes major national and regional insurance carriers, Blue Cross and Blue Shield organizations, various provider-sponsored and independent health plans, third-party administrators (TPAs), self-insured health plans, property and casualty insurers, bill review firms, and other entities involved in the claims settlement process. Established in 1980 and headquartered in New York, New York, Claritev Corporation was previously known as MultiPlan Corporation before officially adopting its current name in February 2025.

Valuation in context

P/E ratio
-1.7
N/A
Not meaningful — company is unprofitable
P/B ratio
-2.1
N/A
Not meaningful — company is unprofitable
EV / EBITDA
9.8
Below average
Below the 10-year average
FCF Yield
-7.9%
Above average
Above the 10-year average
Free · No credit card needed

Get alerted when CTEV is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.